Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Alemany

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Current Pharmaceutical Design|October 25, 2014
Combining oncolytic virotherapy and cytotoxic therapies to fight cancerCristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano, et al.
Human Gene Therapy|September 18, 2008
Coagulation factors determine tumor transduction in vivoMarta Gimenez-Alejandre, Manel Cascallo, Neus Bayo-Puxan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2014
Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapyJordi Martinez-Quintanilla, Derek He, Hiroaki Wakimoto, et al.
Molecular Cancer Therapeutics|November 6, 2009
Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapyJordi Martinez-Quintanilla, Manel Cascallo, Alena Gros, et al.
Human Gene Therapy Methods|September 12, 2013
Adeno-associated virus enhances wild-type and oncolytic adenovirus spreadEduardo Laborda, Cristina Puig-Saus, Manel Cascalló, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Journal of Virology|December 28, 2002
Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deletedMasato Yamamoto, Julia Davydova, Koichi Takayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2021
Evolving Status of Clinical Immunotherapy with Oncolytic AdenovirusMartí Farrera-Sal, Laura Moya-Borrego, Miriam Bazan-Peregrino, et al.
Frontiers in Microbiology|March 1, 2021
Codon Usage and Adenovirus Fitness: Implications for Vaccine DevelopmentJudit Giménez-Roig, Estela Núñez-Manchón, Ramon Alemany, et al.
Molecular Therapy. Oncology|January 6, 2025
Optimized protocol for culturing menstrual blood-derived MSCs for combination with oncolytic adenoviruses in cancer treatmentMarcel Costa-Garcia, Laura Moya-Borrego, Ramon Alemany Bonastre, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Current Pharmaceutical Design|October 25, 2014
Combining oncolytic virotherapy and cytotoxic therapies to fight cancerCristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano, et al.
Human Gene Therapy|September 18, 2008
Coagulation factors determine tumor transduction in vivoMarta Gimenez-Alejandre, Manel Cascallo, Neus Bayo-Puxan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2014
Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapyJordi Martinez-Quintanilla, Derek He, Hiroaki Wakimoto, et al.
Molecular Cancer Therapeutics|November 6, 2009
Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapyJordi Martinez-Quintanilla, Manel Cascallo, Alena Gros, et al.
Human Gene Therapy Methods|September 12, 2013
Adeno-associated virus enhances wild-type and oncolytic adenovirus spreadEduardo Laborda, Cristina Puig-Saus, Manel Cascalló, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Journal of Virology|December 28, 2002
Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deletedMasato Yamamoto, Julia Davydova, Koichi Takayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2021
Evolving Status of Clinical Immunotherapy with Oncolytic AdenovirusMartí Farrera-Sal, Laura Moya-Borrego, Miriam Bazan-Peregrino, et al.
Frontiers in Microbiology|March 1, 2021
Codon Usage and Adenovirus Fitness: Implications for Vaccine DevelopmentJudit Giménez-Roig, Estela Núñez-Manchón, Ramon Alemany, et al.
Molecular Therapy. Oncology|January 6, 2025
Optimized protocol for culturing menstrual blood-derived MSCs for combination with oncolytic adenoviruses in cancer treatmentMarcel Costa-Garcia, Laura Moya-Borrego, Ramon Alemany Bonastre, et al.
Pageof 11